Startup works with leading cell therapy companies to bring robotics manufacturing into the clean room, reducing costs by more than 70% while accelerating output compared with legacy systems.
Multiply Labs is doing for cell therapy labs what has already happened in the chip industry: It’s introducing robots to do the tedious, precision and hygienic work better, faster and cheaper.
The startup concept was sparked when Fred Parietti was at MIT doing PhD research in robotics and he met with Alice Melocchi, who showed him how these laborious labs lacked automation while risking contamination.
“She showed me what she did in a lab and how difficult it was, and I couldn’t believe it — I thought drugs were made like chips, and this was insane but also real,” said Parietti, cofounder and CEO of Multiply Labs. “Next, I flew to Silicon Valley, and we started this at YCombinator.”
San Francisco-based Multiply Labs, founded in 2016, today is automating cell therapy manufacturing with robots for leading companies, including Kyverna Therapeutics and Legend Biotech.
